Leadership

Dr. Haynes invited to speak at UCLA

Posted on

Dr. Haynes has been invited to the University of California Los Angeles (UCLA) to present a talk entitled “A pipeline to engineer synthetic epigenetic proteins derived from chromatin” for the UCLA Bioengineering Department Seminar Series on Thursday, May 17, 2018 in the Engineering V building.

Advertisements

2018 Synthetic Biology: Engineering, Evolution & Design (SEED) is coming to Arizona

Posted on Updated on

Synthetic Biology: Engineering, Evolution & Design (SEED) is an annual conference that has been hosted in different cities since 2014: Manhattan Beach, CA; Boston, MA; Chicago, IL; and Vancouver, Canada. This year the rapidly growing, highly-visible meeting will take place in Scottsdale, AZ! SEED 2018 will focus on advances in science, technology, applications, and related investments in the field of synthetic biology. This year’s theme will be “synthetic biology at the leading edge of massive DNA synthesis, editing, and decoding.”

The Meeting Chairs are Karmella Haynes (ASU) and Ryan Gill (UC Boulder).

Keynote speakers will include Jim Collins (MIT), Jay Keasling (UC Berkeley), Floyd Romesberg (Scripps), and Pam Ronald (UC Davis).

The call for poster abstracts is open until May 26, 2018.

If you are interested in supporting the conference, please visit the webpage, SEED: Become a Sponsor or Exhibitor, for more information.

Dr. Haynes invited to speak at UC Irvine

Posted on

Dr. Haynes has been invited to the University of California Irvine to present a talk entitled “In Vitro Development of Chromatin-based Biologics for Breast Cancer” for the UCI Biomedical Engineering Lecture Series on Friday, October 20, 2017 in the McDonnell Douglas Engineering Auditorium (MDEA).

Dr. Haynes invited to help chart paths of synthetic biology in Paris

Posted on Updated on

CRI_ParisDr. Haynes has been invited by scientists at the Center for Research and Interdisciplinarity (CRI) to speak at “Charting Future Paths of Open Synthetic Biology” in Paris, France. She will present a talk entitled “Engineering the human genome as chromatin” and participate in advising a strategy (white paper) for the recruitment and support of research fellows in synthetic biology. The invitation to this important international event was given in recognition of Dr. Haynes’ participation at the leading edge of synthetic biology and her high-impact contributions to the field.

News: “Soft” Side of Bioengineering Poised to Make Big Impacts

Posted on Updated on

ASU Full Circle recently highlighted the emerging Molecular, Tissue, and Cellular Bioengineering (MCTB) community at ASU and the second annual MCTB Symposium, co-chaired by Karmella Haynes.

J. Kullman, 07.27.17, ASU Full Circle: There are more technically precise descriptions of what’s at the core of a growing trend broadening the horizons of biomedical engineering than “the soft, squishy side of bioengineering.” But Karmella Haynes and Kaushal Rege still like the way that sums up what they and about 20 other Arizona State University faculty members are increasingly focusing on in their research and teaching.”

Read more at ASU Full Circle.

Dr. Haynes receives SBHSE Outstanding Assistant Professor Award 2016-2017

Posted on

Dr. Haynes received an award for SBHSE Outstanding Assistant Professor 2016-2017. Awardees are evaluated based on yearly performance and selected by the Director of the School of Biological and Health Systems Engineering.

Dr. Haynes to Present at Lawrence University’s Recent Advances in Biology

Posted on

Dr. Haynes was invited to present her research in the seminar series Recent Advances in Biology hosted by the Biology Department at Lawrence University in Appleton, Wisconsin. The organizers of Recent Advances in Biology invite select speakers from other Universities to addresses issues and advances in biological research. The presentations expose students to the latest discoveries in a wide range of biological disciplines. Dr. Haynes will present a talk on engineering proteins to control gene expression in cancer cells on Monday, April 10.